Arranta Bio, a contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, has completed the sale of its process development and GMP clinical manufacturing site in Gainesville, Florida, to Inceptor Bio and the transfer of client programs and key technical employees to Arranta’s Watertown, MA facility.  “We are delighted that Inceptor Bio will build on the foundation that we established in Gainesville and wish them every success in developing life-saving cell...